{"id":"NCT02139046","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout","officialTitle":"A Phase 3, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04","primaryCompletion":"2015-11","completion":"2015-11","firstPosted":"2014-05-15","resultsPosted":"2016-11-03","lastUpdate":"2016-11-03"},"enrollment":1790,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Gout"],"interventions":[{"type":"DRUG","name":"Febuxostat IR","otherNames":["Uloric"]},{"type":"DRUG","name":"Febuxostat XR","otherNames":["Uloric"]},{"type":"DRUG","name":"Febuxostat placebo","otherNames":[]},{"type":"DRUG","name":"Colchicine","otherNames":[]},{"type":"DRUG","name":"Naproxen","otherNames":[]},{"type":"DRUG","name":"Lansoprazole","otherNames":[]}],"arms":[{"label":"Febuxostat IR 40 mg","type":"ACTIVE_COMPARATOR"},{"label":"Febuxostat IR 80 mg","type":"ACTIVE_COMPARATOR"},{"label":"Febuxostat XR 40 mg","type":"EXPERIMENTAL"},{"label":"Febuxostat XR 80 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of febuxostat 40 mg extended release (XR) and 80 mg XR in comparison with febuxostat 40 mg immediate release (IR) and 80 mg IR, respectively, in participants with gout.","primaryOutcome":{"measure":"Percentage of Participants With Serum Urate <5.0 mg/dL at Month 3","timeFrame":"Month 3","effectByArm":[{"arm":"Placebo","deltaMin":0.3,"sd":null},{"arm":"Febuxostat IR 40 mg","deltaMin":15.7,"sd":null},{"arm":"Febuxostat XR 40 mg","deltaMin":25.9,"sd":null},{"arm":"Febuxostat IR 80 mg","deltaMin":42.6,"sd":null},{"arm":"Febuxostat XR 80 mg","deltaMin":50.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG004","p":"<0.001"},{"comp":"OG001 vs OG002","p":"0.001"},{"comp":"OG003 vs OG004","p":"0.043"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":192,"countries":["United States"]},"refs":{"pmids":["30073793"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":356},"commonTop":["Diarrhoea","Hypertension","Nasopharyngitis","Arthralgia","Upper respiratory tract infection"]}}